文献速递瓣膜外科

主动脉内阻断机器人二尖瓣修复的早期经验

Early experience with robotic mitral valve repair with intra-aortic occlusion.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-12-06

本研究在大学教学医院开展机器人二尖瓣修复项目后,比较142例退行性二尖瓣反流患者的机器人修复与倾向性评分匹配的胸骨正中切开对照的早期结果。机器人组修复率98.6%,胸骨正中切开组97.9%;机器人组手术、体外循环、主动脉阻断和通气时间更长,但学习曲线内显著缩短。机器人组3例术后因低心排需体外膜肺氧合,1例死亡。

要点

  • 机器人组与胸骨正中切开组修复率分别为98.6%和97.9%。
  • 胸骨正中切开组手术、体外循环、主动脉阻断和通气时间更短。
  • 机器人组3例术后需体外膜肺氧合,1例死亡,严重并发症较多。

核心结论

  • 本系列报告了本院引入机器人二尖瓣修复的整个早期学习曲线,修复率和早期耐久性可接受,但机器人组严重并发症患者更多。
  • 早期发生的重大机器人并发症可能与同期使用主动脉内阻断有关。

研究设计与样本

  • 2011年5月至2015年12月,共142例因退行性二尖瓣反流行机器人二尖瓣修复。
  • 采用倾向性评分分析选择常规胸骨正中切开对照组,形成2组匹配良好的研究组。

主要发现

  • 机器人组和胸骨正中切开组瓣膜修复率分别为98.6%和97.9%。
  • 胸骨正中切开组手术长度、体外循环、主动脉阻断和通气时间均短于机器人组。
  • 机器人组学习曲线期间上述时间均统计学显著缩短。
  • 两组围术期并发症率无统计学显著差异,但机器人组3例术后因低心排需体外膜肺氧合,1例死亡。
  • 机器人组和胸骨正中切开组最新随访时二尖瓣反流≤1+者分别为86.3%和84.7%,随访期间生存率或再手术率无统计学显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the learning curve and early results of robotic mitral valve repairs in comparison with propensity score-matched sternotomy controls after the adoption of a robotic mitral valve surgery program in a university teaching hospital. METHODS: A total of 142 patients underwent robotic mitral valve repair due to degenerative mitral regurgitation between May 2011 and December 2015. Control patients operated on via the conventional sternotomy approach were selected by the use of propensity score analysis resulting in 2 well-matched study groups. RESULTS: Valve repair rate was 98.6% and 97.9% in the robotic and sternotomy groups, respectively. Operation length, cardiopulmonary bypass, aortic crossclamp, and ventilation times were shorter in the sternotomy group. All of these times were statistically significantly reduced within the robotic group during the learning curve. Even though there was no statistically significant difference in the rate of perioperative complications between the groups, 3 patients in the robotic group required postoperative extracorporeal membrane oxygenation due to low cardiac output, and 1 patient in the robotic group died. In the robotic and sternotomy groups, 86.3% versus 84.7% of patients had grade ≤1+ mitral valve regurgitation at the latest follow-up visit, and there was no statistically significant difference in survival or reoperation rate between the 2 study groups during follow-up. CONCLUSIONS: The present series reports the entire early learning curve related to the introduction of robotic mitral valve repair in our institution. In all, repair rate and early durability were acceptable, but more patients in the robotic group had serious complications. Early major robotic complications that occurred may have been related to the simultaneous use of intra-aortic occlusion.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kesävuori R, Raivio P, Jokinen JJ, et al. Early experience with robotic mitral valve repair with intra-aortic occlusion. J Thorac Cardiovasc Surg. 2017. PMID: 29221742. doi:10.1016/j.jtcvs.2017.10.076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。